Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Gastroparesis
Interventions
DRUG

[2-13C] uracil

po, in the form of semi-solid meal, granules, once a period

DRUG

[2-13C] uracil, placebo

po, in the form of semi-solid meal, granules, once a period

Trial Locations (1)

53704

Covance Clinical Pharmacology, Inc., Madison

All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

NCT01074710 - Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers | Biotech Hunter | Biotech Hunter